Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$6.86 0.21 | 3.16%

05/24/13 - 04:00 PM ET

Company Cash Flow

Cash Flow From Operating Activities
	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Net Income (Loss)	-46.28M	53.82M	-38.46M	460.24K
Operating Gains/Losses	0.00	-16.27M	0.00	0.00
Extraordinary Gains / Losses	0.00	0.00	0.00	0.00
(Increase) Decrease In Receivables	-675.00K	29.00K	-1.13M	-1.47M
(Increase) Decrease in Inventories	-1.15M	0.00	0.00	0.00
(Increase) Decrease In Other Current Assets	0.00	0.00	0.00	0.00
(Decrease) Increase In Payables	-1.10M	-1.10M	5.21M	1.81M
(Decrease) Increase In Other Current Liabilities	0.00	138.00K	0.00	0.00
(Increase) Decrease In Other Working Capital	229.00K	1.24M	64.00K	359.71K
Other Non-Cash Items	1.10M	-77.04M	241.00K	112.12K
Net Cash From Continuing Operations	-47.20M	-38.21M	-32.54M	2.63M
Net Cash From Discontinued Operations	0.00	2.02M	0.00	0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	-47.20M	-36.18M	-32.54M	2.63M
Sale of Property, Plant & Equipment	0.00	0.00	0.00	0.00
Cash Used for Investing Activities
Sale of Short-Term Investments	49.47M	26.87M	58.90M	28.62M
Purchases of Property, Plant & Equipment	-753.00K	-685.00K	-294.00K	-714.48K
Acquisitions	0.00	0.00	0.00	0.00
Purchases of Short-Term Investments	-97.67M	-17.89M	-32.78M	-56.29M
Other Cash from Investing Activities	0.00	0.00	0.00	0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	-48.96M	33.90M	25.82M	-28.39M
Issuance of Debt	0.00	30.00M	0.00	0.00
Cash Used for Financing Activities
Issuance of Capital Stock	100.74M	29.00K	4.00K	19.78K
Repayment of Long-Term Debt	-6.78M	0.00	0.00	0.00
Repurchase of Capital Stock	0.00	0.00	0.00	0.00
Payment of Cash Dividends	0.00	0.00	0.00	0.00
Other Financing Charges, Net	-6.04M	-975.00K	-947.00K	4.26M
Net Cash From Financing Activities	87.92M	27.09M	-943.00K	4.28M
Effect of Exchange Rate Changes	0.00	0.00	0.00	0.00
Net Change in Cash & Cash Equivalents	-8.24M	24.80M	-7.66M	-21.47M